ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’

| Press | No Comments
The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World Evidence-Based Healthcare (EBHC) Day blog, introducing ERA4TB’s aims and work. This piece reflects on how partnerships…

Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project [TB Alliance]

| Press | No Comments
TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the European Regimen Accelerator for Tuberculosis (ERA4TB) project. Funded by the European Union Innovative Medicines Initiative…

COVID-19 highlights urgent need to reboot global effort to end tuberculosis [Press Release – WHO]

| Press | No Comments
An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in 2019, according to preliminary data compiled by the World Health Organization (WHO) from over 80…

ERA4TB Press Release

| Press | No Comments
Innovative Medicines Initiative Launches European Regimen Accelerator For Tuberculosis (ERA4TB) project.


| Press | No Comments
European Regimen Accelerator For Tuberculosis (ERA4TB) project starts.

Know how accelerate the development of new treatment regimens for tuberculosis, discover our project

The Project